Mubadala Sells Minority Stake in Arcadia Following Acquisition by Bansk Group

Philip Yifei Bao, director of Private Equity at Mubadala, highlighted the collaborative success of the partnership. “It has been a privilege to partner with Bansk, Mike DeBiasi, and the Arcadia team over the past four years,” he said, according to a WAM report. Bao noted that the company played a pivotal role in transforming Arcadia into a top North American platform, driving organic growth and integrating strategic acquisitions, including Avrio and CloSYS.

During Mubadala’s four-year tenure, Arcadia experienced a remarkable growth trajectory. Revenues tripled, while profitability improved significantly, reflecting a combination of operational efficiencies and strategic expansion efforts. Bao expressed confidence in the company’s future under its new ownership. “We are confident that Arcadia will thrive under the continued stewardship of Bansk, and we wish them every success as they embark on this next chapter,” he added.

Bart Becht, senior partner and chairman at Bansk, praised Mubadala’s involvement and its long-term, hands-on approach. “Their commitment to responsible stewardship played a key role in accelerating Arcadia’s growth and setting the company up for sustained success,” Becht said.

Arcadia, headquartered in the United States, has positioned itself as a leader in the consumer health and wellness sector, offering a portfolio of products that spans oral care, nutritional supplements, and personal health solutions. The company has strategically expanded through acquisitions such as Avrio, known for its functional foods and beverages, and CloSYS, a trusted oral care brand. These moves strengthened Arcadia’s market presence and enhanced its capabilities in innovation, distribution, and consumer engagement.

Mubadala’s exit marks a milestone in its broader investment strategy, which focuses on fostering sustainable growth in high-potential consumer and healthcare businesses globally. By partnering with Bansk, the investment firm helped guide Arcadia through a period of rapid expansion while maintaining a focus on operational excellence and strategic positioning in North America.

The acquisition by Bansk is expected to accelerate Arcadia’s next phase of growth. The firm has indicated plans to continue building on the foundation established during Mubadala’s tenure, supporting further product innovation, market expansion, and integration of digital and direct-to-consumer capabilities.

The transaction underscores a growing trend of private equity firms collaborating to scale consumer health platforms in North America, leveraging both operational expertise and capital to capture long-term market opportunities.